Tuesday 28 August 2018

Reuters Health Report: UK rejects Gilead's CAR-T cancer cell therapy as too expensive

Reuters.com Newsletter

UK rejects Gilead's CAR-T cancer cell therapy as too expensive

A cutting-edge CAR-T cell therapy for otherwise untreatable forms of blood cancer is too expensive to justify its use on Britain's state-funded health service, the country's healthcare cost agency NICE said on Tuesday.

Almost one in 20 U.S. adults now use e-cigarettes

(Reuters Health) - Roughly 10.8 million American adults are currently using e-cigarettes, and more than half of them are under 35 years old, a U.S. study suggests.

FDA proposes restricting compounding of three drug substances

The U.S. Food and Drug Administration on Monday proposed excluding three substances from a list of ingredients that could be used to manufacture compounded medications in bulk for use by hospitals and doctors' offices.

Depression in pregnancy may alter babies' brains

(Reuters Health) - Women with depression and anxiety during pregnancy may be more likely to have babies with altered brain development that might be linked to behavior problems later in childhood, a small study suggests.

Weight loss drug lorcaserin found safe in large study

(Reuters Health) - Eisai's weight loss drug lorcaserin does not increase people's risk of major cardiovascular events, according to data from a study of 12,000 overweight or obese patients.

FDA declines to approve Akcea-Ionis genetic disease drug

The U.S. Food and Drug Administration on Monday declined to approve a drug from Akcea Therapeutics Inc and Ionis Pharmaceuticals that aims to treat a genetic disease that causes fat accumulation in the blood.

One in seven U.S. adults used marijuana in 2017

(Reuters Health) - With more and more states legalizing marijuana, whether for medical use, recreational use, or both, increasing numbers of Americans are using cannabis. A new survey finds that one in seven had used marijuana in 2017, with smoking being the most common manner of consumption, according to a report published in the Annals of Internal Medicine.

FDA approves Tetraphase Pharma's antibiotic

Tetraphase Pharmaceuticals Inc said on Monday U.S. health regulators approved its drug to treat complicated intra-abdominal infections, providing a new option to combat the growing threat from treatment-resistant bacteria.

Fewer middle-aged stroke survivors skip medicines under Obamacare

(Reuters Health) - With increased access to insurance under the Affordable Care Act (ACA), known as Obamacare, fewer middle-aged stroke survivors are skipping medications that they previously might have struggled to afford, a U.S. study suggests.

Seniors healthier when medical care is coordinated

(Reuters Health) - As America's population ages, experts are exploring how best to keep older people with multiple chronic illnesses healthy. A new study suggests that coordination between physicians may be key.

Esperion's combo therapy lowers cholesterol level by 35 percent, shares surge

Esperion Therapeutics Inc said on Monday a combination of its drug, bempedoic acid, taken along with Merck's Zetia lowered cholesterol level by 35 percent in a late-stage study, sending the company's shares up as much as 11 percent.

Related Videos

Prolific playwright Neil Simon dies at 91 -NYT

INSIGHT: Haj pilgrims 'stone the devil'

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS